Read + Share
Song Y, Zhou K, Zou DH, Zhou J, et al. Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and
safety results from a phase 2 study. Blood 2022 Mar 18. pii: 484435. doi: 10.1182/blood.2021014162.
PMID: 35303070
|
 |
|
Song Y, Zhou K, Zou DH, Zhou J, et al. Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and
safety results from a phase 2 study. Blood 2022 Mar 18. pii: 484435. doi: 10.1182/blood.2021014162.
PMID: 35303070
|
|
|
|